Adam R Johnson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Adam R Johnson

Showing results (51-60 of 52) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 52 results.

Nature Communications|January 14, 2018

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosusHans D Brightbill, Eric Suto, Nicole Blaquiere, et al.

Journal of Medicinal Chemistry|March 3, 2024

Discovery of TRPA1 Antagonist <b>GDC-6599</b>: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory DiseaseJack A Terrett, Justin Q Ly, Paula Katavolos, et al.

Pageof 6

Search research articles

Showing results (51-60 of 52) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 52 results.

Nature Communications|January 14, 2018

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosusHans D Brightbill, Eric Suto, Nicole Blaquiere, et al.

Journal of Medicinal Chemistry|March 3, 2024

Discovery of TRPA1 Antagonist <b>GDC-6599</b>: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory DiseaseJack A Terrett, Justin Q Ly, Paula Katavolos, et al.

Pageof 6